ERFO.MI

Laboratorio Farmaceutico Erfo S.p.A.
MilanEUREQUITY Consumer Defensive DELAYED
Last price
1.13
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
1.13
Day high
1.15
Day low
1.13
Volume
10.00K
Market cap
$9.63M
P/E (TTM)
28.13
52W range
1.01 – 1.80

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-1.32% +0.1%
1M
-1.32% -5.0%
3M
+2.27% -0.8%
6M
-16.67% -27.7%
YTD
-23.47% -35.8%
1Y
-26.95% -46.9%
3Y
+7.14% -67.0%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on ERFO.MI open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
5.23M
Total on file

Fundamentals

TTM · reported
Market cap$9.63M
Enterprise value$10.30M
Revenue (TTM)$9.73M
Gross profit$3.70M
EBITDA$1.83M
Net income$736.97K
EPS (TTM)$0.04
Free cash flow$-1.60M
Total cash$1.05M
Total debt$1.35M
Book value / share$0.93
Shares outstanding8.56M
Float2.99M
Short % of float
Dividend yield
Beta (5Y)1.24

Valuation & profitability ratios

Account required
Trailing P/E28.13
Forward P/E
PEG ratio
Price / sales
Price / book1.20
EV / revenue1.06
EV / EBITDA5.62
Gross margin37.97%
Operating margin6.92%
Profit margin7.57%
Return on equity9.25%
Return on assets6.13%
Debt / equity16.10
Current ratio2.00
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 1 quarters
Blank means not reported, not zero
Line item20252024202320222021YoY
Total revenue $9.66M$5.93M$4.72M$4.82M
Operating revenue $9.66M$5.93M$4.72M$4.82M
Cost of revenue $2.94M$3.33M$2.27M$1.37M
Gross profit $6.72M$2.60M$3.40M$3.45M
Selling, general & admin $657.00K
Total operating expense $5.57M$3.76M$1.68M$2.34M +48.4%
Operating income $1.15M$600.33K$918.50K$1.06M +90.8%
Net interest income -$23.78K-$22.49K-$38.53K-$12.21K
Pre-tax income $1.04M$815.16K$948.51K$1.56M
Tax provision $305.45K$224.83K$232.43K$389.86K
Net income $381.62K$366.98K$553.82K$716.07K +4.0%
Net income to common $381.62K$366.98K$553.82K$716.07K +4.0%
Basic EPS 0.040.040.070.08 +7.9%
Diluted EPS 0.040.040.070.08 +7.9%
EBIT $1.10M$844.92K$987.15K$1.57M
EBITDA $2.02M$1.56M$1.61M$2.02M
Basic shares 8.52M8.60M9.00M9.00M
Diluted shares 8.52M8.60M9.00M9.00M

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $0
Next quarter $0
Current year $0
Next year $0

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders61.40%
Held by institutions0.00%
Institutions holding0
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
1.13
-0.88% from price
SMA 20
1.14
-1.16% from price
SMA 50
1.15
-2.10% from price
SMA 100
1.14
-1.38% from price
SMA 200
1.26
-10.80% from price
EMA 12
1.14
-1.23% from price
EMA 26
1.14
-1.54% from price
EMA 50
1.15
-1.81% from price
RSI (14)
45.6
Neutral
MACD (12,26,9)
-0.00
Hist -0.00
ATR (14)
0.02
2.03% of price
Realised vol 30D
27.3%
Annualised
Bollinger upper
1.18
20, 2σ
Bollinger lower
1.10
20, 2σ
50 / 200 cross
Death
1.15 vs 1.26
Trend bias
Below 200
-10.80%

Options chain

Account required
ExpirySpot 1.13
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.26
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
27.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-41.2%
Peak to trough
Max drawdown 5Y
-72.4%
Peak to trough
ATR 14
0.02
2.03% of price
Beta (reported)
1.24
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.